RFK Jr. cuts red tape on biosimilar drugs to lower prescription costs

The FDA announced draft guidance to cut red tape on biosimilar production and access in the hopes of reducing prescription ...

FDA approves a new drug for hot flashes. Here’s what to know about it.

Elinzanetant belongs to a new class of drugs designed to target what is believed to be a key mechanism responsible for ...

Trump Administration Eases Approval Process for Biosimilar Drugs

The Trump administration is proposing changes to Food and Drug Administration guidelines that would make it less expensive ...

Federal health officials push effort to spur cheaper biotech drugs

Federal regulators are trying to make it easier to develop cheaper alternatives to powerful drugs that many Americans depend ...

Q&A: New drug being reviewed by the FDA to treat Parkinson's disease

The U.S. Food and Drug Administration is reviewing a new Parkinson's disease drug called tavapadon that could give people ...

Reining in drug prices, ballroom saga, teens and chatbots: Catch up on the day’s stories

The ligament in your elbow that connects the bone in your upper arm to the one in your forearm is only about as strong as “a ...

F.D.A. Moves to Speed Approvals for Cheaper Copycat Drugs

The agency announced moves to cut regulatory obstacles for the makers of biosimilar drugs, which are akin to generics and may ...

Paxton sues Tylenol's maker as Trump administration links the drug to autism

Texas Attorney General Ken Paxton alleged Johnson & Johnson deceptively marketed the drug as safe for pregnant Texans.

FDA to streamline approvals for generic biological drugs in latest move targeting health costs

The US Food and Drug Administration will take steps to streamline the process to develop generic versions of complex ...